Continuous subcutaneous insulin infusion. | |||
|
An article from Diabetes Care 1999 Nov;22(11):1779-84
by Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV Yale Children's Clinical Research Center, Yale University School of Nursing, New Haven, Connecticut, USA. elizabeth.boland@yale.edu
[Medline record in process]
So what's all this in English??
See: PubMed PMID: 10546007, UI: 20013330 for Abstract of article.The study compared a group of adolescents on Mult. Daily Injections to a group on CSII. Both groups received intensive treatment that included routine visits every 4-6 weeks with Certified Diabetes Educators (MD's, Nurse Practioners, Dieticians, Social Workers). They received diabetes education, CHO counting and "taught how to vary insulin doses based on varied food intake or exercise." The results of the study showed the following: 1. HbA1c Baseline 6 months 12 months MDI 8.8 8.1 8.3 CSII 8.4 7.7 7.5 MDI begins to rebound while CSII continues to decline 2. The rate of severe hypoglycemic events of the CSII group was almost 50% that of MDI CSII 76 MDI 134 3. Pump patients used less insulin 4. No significant difference in DKA episodes 5. Adolescents using pumps found coping with diabetes to be less difficult than adolescents using MDI This study clearly show the benefits of pumps over injections in acheiving sustained improvements in the control of diabetes even when all of patients receive intensive education and support.